Invention Grant
US08273797B2 Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde
有权
使用4- [双[2 - [（甲基磺酰基）氧基]乙基]氨基] -2-甲基 - 苯甲醛治疗肾癌
![Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde](/docs/US/2012-09-25/US08273797B2/abs.jpg.600x600.jpg)
- Patent Title: Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde
- Patent Title (中): 使用4- [双[2 - [（甲基磺酰基）氧基]乙基]氨基] -2-甲基 - 苯甲醛治疗肾癌
-
Application No.: US13176129Application Date: 2011-07-05
-
Publication No.: US08273797B2Publication Date: 2012-09-25
- Inventor: Susan D. Mertins , Susan E. Bates , David G. Covell , Geoffrey W. Patton , Melinda G. Hollingshead , Rao Vishnuvajjalla
- Applicant: Susan D. Mertins , Susan E. Bates , David G. Covell , Geoffrey W. Patton , Melinda G. Hollingshead , Rao Vishnuvajjalla
- Applicant Address: US DC Washington
- Assignee: The United States of America, as represented by the Secretary of the Department of Health and Human Services
- Current Assignee: The United States of America, as represented by the Secretary of the Department of Health and Human Services
- Current Assignee Address: US DC Washington
- Agency: Klarquist Sparkman, LLP
- Main IPC: A61K31/136
- IPC: A61K31/136
![Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde](/abs-image/US/2012/09/25/US08273797B2/abs.jpg.150x150.jpg)
Abstract:
The present invention features methods of treating a mammalian subject having renal cancer by administration of 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde. The present invention further features administration protocols and dosing schedules for methods of treating patients having renal cancer and pharmaceutical compositions suitable for use in the treatment methods provided herein.
Public/Granted literature
- US20110269840A1 TREATING RENAL CANCER USING A 4-[BIS[2-[(METHYLSULFONYL)OXY]ETHYL]AMINO]-2-METHYL-BENZALDEHYDE Public/Granted day:2011-11-03
Information query
